AI-Powered skin patch could bring TB prevention to People's doorsteps
NCT ID NCT07714707
First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time
Summary
This study explores whether community health workers can use a new skin test, with or without AI help, to test close contacts of TB patients at home instead of at a clinic. The goal is to make it easier for people, especially children and families in Tajikistan and Tanzania, to get tested and start preventive treatment. Researchers will compare home-based testing to clinic-based testing to see which approach leads to more people completing their full course of TB prevention.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CY-TB Patch (a skin test patch) and TB Connect app (AI-assisted reading tool)
- What this could lead to
- If successful, this approach could make TB preventive care more accessible and increase treatment completion rates, reducing TB spread in high-burden communities.
- What could go wrong
- This is an implementation study, not a drug trial, so it tests logistics and feasibility rather than a new cure. Results may vary between countries and settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TPT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
KNCV Tajikistan
Dushanbe, Tajikistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
KNCV Tanzania
Dar es Salaam, Dar es Salaam Region, Tanzania
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Community-Driven TB screening aims to reach vulnerable immigrants
- Shorter TB regimens could simplify treatment
- AI could revolutionize TB care by predicting who needs shorter treatment
- New study tracks TB drugs in breastmilk to protect infants
- TB drug liver risk under the microscope
- New study aims to catch TB in pregnant women earlier